Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | GFER | P55789 | 1/20 | 0.51 |
| ▸ | RARB | P10826 | 5/20 | 0.50 |
| ▸ | RARA | P10276 | 5/20 | 0.50 |
| ▸ | RARG | P13631 | 4/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.49 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.49 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.49 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.49 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14627878 | 0.92 | RARB (0.44) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL403671 | 0.87 | HDAC11 (0.61) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL30179323 | 0.87 | HDAC11 (0.61) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL1913921 | 0.86 | RARB (0.44) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL6033366 | 0.86 | MEN1 (0.47) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL7687459 | 0.82 | MEN1 (0.59) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL3755595 | 0.81 | MEN1 (0.55) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL549446 | 0.80 | MEN1 (0.73) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL25558997 | 0.79 | MEN1 (0.43) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL24259966 | 0.79 | ALDH1A1 (0.52) | MEN1KMT2APOLBGAAGFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010697-A | Preparation method of adapalene key intermediate | 江苏联环药业股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-117736071-A | Method for continuously preparing 2- ((3 r,5r,7 r) -adamantan-1-yl) -4-bromophenol | 南京恒道医药科技股份有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-101955417-B | Method for preparing 2-(1-adamantyl)-4-bromophenol | UNIV EAST CHINA SCIENCE & TECH | 2013-01-02 | — | — | CN | claimed |
| CN-101955417-A | Method for preparing 2-(1-adamantyl)-4-bromophenol | UNIV EAST CHINA SCIENCE & TECH | 2011-01-26 | — | — | CN | claimed |
| CN-1827582-A | Process for preparing 6-[3-(1-adamantyl)-4-methoxy phenyl]-2-methyl naphthoate | JIANGSU ZHONGDAN CHEMICAL GROU (CN) | 2006-09-06 | — | — | CN | claimed |
| CN-122010697-A | Preparation method of adapalene key intermediate | 江苏联环药业股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20260035353-A1 | PHENOL DERIVATIVES FOR USE AS ANTIMICROBIAL, ANTIBACTERIAL, BACTERICIDE | SPECIAL PRODUCTS LINE S P A (IT) | 2026-02-05 | — | — | US | disclosed |
| US-20250277065-A1 | Substituted Pyridine-2,6-bis(phenylenephenolate) Complexes with Enhanced Solubility that are Useful as Catalyst Components for Olefin Polymerization | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2025-09-04 | — | — | US | disclosed |
| CN-119684107-A | Method for purifying adapalene bulk drug | 河北华晨药业集团有限公司 | 2025-03-25 | — | — | CN | disclosed |
| EP-4519331-A1 | SUBSTITUTED PYRIDINE-2,6-BIS(PHENYLENEPHENOLATE) COMPLEXES WITH ENHANCED SOLUBILITY THAT ARE USEFUL AS CATALYST COMPONENTS FOR OLEFIN POLYMERIZATION | ExxonMobil Chemical Patents Inc. (US) | 2025-03-12 | — | — | EP | disclosed |
| EP-3519383-B1 | RETINOID DERIVATIVES WITH ANTITUMOR ACTIVITY | BIOGEM S C A R L (IT) | 2024-08-21 | — | — | EP | disclosed |
| CN-117736071-A | Method for continuously preparing 2- ((3 r,5r,7 r) -adamantan-1-yl) -4-bromophenol | 南京恒道医药科技股份有限公司 | 2024-03-22 | — | — | CN | disclosed |
| US-4940696-A | Benzonaphthalene derivatives and their use in therapeutic and cosmetic compositions | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIOUES (CIRD) (FR) | 1990-07-10 | — | — | US | disclosed |
| US-4927928-A | SKIN DISORDERS, EYES, ANTITUMOR | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES C.I.R.D. (FR) | 1990-05-22 | — | — | US | disclosed |
| US-4920140-A | Skin disorders | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES C.I.R.D. (FR) | 1990-04-24 | — | — | US | disclosed |
| EP-0199636-B1 | BENZONAPHTHALENIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN PHARMACY AND COSMETICS | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES C.I.R.D. Groupement d'Intérêt Economique dit: (FR) | 1989-02-08 | — | — | EP | disclosed |
| US-4740519-A | Benzo (b) thiophene carboxylate derivatives and pharmaceutical compositions | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES C.I.R.D. (FR) | 1988-04-26 | — | — | US | disclosed |
| US-4717720-A | DERMATOLOGIC DISEASES, CONJUCTIVE TISSUE DEGENERATION AND ANTI-TUMOR ACTIVITY | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (C.I.R.D.) (FR) | 1988-01-05 | — | — | US | disclosed |
| EP-0232199-A2 | Aromatic benzamido compounds, process for their preparation and their use in human or veterinary medicine as well as in cosmetics | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA - CIRD GALDERMA (FR) | 1987-08-12 | — | — | EP | disclosed |
| EP-0199636-A1 | Benzonaphthalenic derivatives, process for their preparation and their use in pharmacy and cosmetics | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES C.I.R.D. Groupement d'Intérêt Economique dit: (FR) | 1986-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035353-A1 | PHENOL DERIVATIVES FOR USE AS ANTIMICROBIAL, ANTIBACTERIAL, BACTERICIDE | TLR7, GANC, ARG1 | MEN1 4747/4885KMT2A 4794/4885POLB 1748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.